Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world data
Findings imply that substantial proportion of patients continue to show limited treatment response and treatment refractoriness even after multiple lines of therapy.
Authors
- Hua Chen (ORCID: https://orcid.org/0000-0001-7889-8023)
- Susan Abughosh (ORCID: https://orcid.org/0000-0002-8779-8523)
- Bilqees Fatima
- Zahra Majd (ORCID: https://orcid.org/0000-0003-2776-5401)
- Ning Lyu (ORCID: https://orcid.org/0000-0003-2844-4685)
- Zhen Zeng (ORCID: https://orcid.org/0000-0002-8120-0973)
Institutions
- University of Houston (US)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100921
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00